RT Journal Article
SR Electronic
T1 The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.21.21253498
DO 10.1101/2021.03.21.21253498
A1 Teyssou, Elisa
A1 Soulie, Cathia
A1 Visseaux, Benoit
A1 Lambert-Niclot, Sidonie
A1 Ferre, Valentine
A1 Marot, Stéphane
A1 Jary, Aude
A1 Sayon, Sophie
A1 Zafilaza, Karen
A1 Leducq, Valentin
A1 Schnuriger, Aurélie
A1 Abdi, Basma
A1 Wirden, Marc
A1 Houhou-Fidouh, Nadhira
A1 Charpentier, Charlotte
A1 Morand-Joubert, Laurence
A1 Burrel, Sonia
A1 Descamps, Diane
A1 Calvez, Vincent
A1 Geneviève Marcelin, Anne
YR 2021
UL http://medrxiv.org/content/early/2021/05/03/2021.03.21.21253498.abstract
AB The 501Y.V2 and the 501Y.V1 SARS-CoV-2 variants emerged and spread rapidly into the world. We analysed the viral load of 643 nasopharyngeal samples of COVID-19 patients at diagnosis and found that the 501Y.V1 and the 501Y.V2 variants presented a viral load three to ten times and two times higher than the historical variants, respectively.HighlightsViral load in COVID-19 patient nasopharyngeal samples was different between variants.The 501Y.V2 variant had a viral load 2 times higher than the historical variantsThe 501Y.V2 variant had a viral load slightly lower than the 501Y.V1The 501Y.V1 variant had a viral load 3-10 times higher than the historical variantsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The CNIL (National Commission for Informatics and Freedoms) has authorized APHP (Assistance Publique - Hopitaux de Paris) to implement an automated processing of personal data to setting up the health data warehouse (EDS). This authorization allow the possibility of using the EDS to conduct non-interventional research on data in a scope beyond the care team, for which the use was already covered by a normal declaration. In APHP, all patients have been informed at their entrance by doctors that theirs data could be used for researche purposes except if they do not give their consent. This information is also reminding in the result report given to the patient. CNIL referent for AP-Sorbonne univiersity : Patrick Lefebvre All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall the data in this manuscript are available. The data are presented on an excel format. Contact to obtaine data: elisa.teyssou{at}aphp.fr